Company: ARAI
Filing Date: 2025-06-05
Form Type: 10-Q
Source: 0001641172-25-013826
Chunk: 22

Company: Arrive AI Inc.
Filing Date: 2025-06-05
Form: 10-Q
Item: Part I, Item 1
Chunk 22
---
 the three months ended March 31, 2025:

SCHEDULE
OF NONVESTED SHARE OPTION 

    Nonvested
    Share Options  
    Weighted
    Average Exercise Price  
    Weighted
    Average Grant Date Fair Value  
    Weighted
    Average Remaining Contractual Term (years)  
    Aggregate
    Intrinsic Value 

    BALANCE,
    DECEMBER 31, 2024 
     452,875  
    $0.80  
    $10.89  
     8.88  
    $5,396,007 

    Vested 
     (22,410) 
     0.79  
     10.93  
     8.66  
     273,582 
  
    Canceled/Expired 
     (1,160) 
     0.76  
     11.36  
     -  
     - 

    BALANCE,
    MARCH 31, 2025 
     429,305  
    $0.80  
    $10.88  
     8.18  
    $5,239,559 

The
aggregate intrinsic value is calculated as the difference between the exercise price of the underlying share options and the closing
stock price of $13.00 for the Company’s common shares on March 31, 2025 and the closing stock price of $12.71 for the Company’s
common shares on December 31, 2024.

There
were no options granted during the three months ended March 31, 2025. As of March 31, 2025, there was $4,672,620 unrecognized compensation
expense related to nonvested stock options to be recognized over the remaining vesting period. Total compensation expense related to
stock options during the three months ended March 31, 2025 was $244,883. No options were exercised during the three months ended March
31, 2025.

     - 21 - 

ARRIVE
                                            AI INC. 

(FORMERLY
ARRIVE TECHNOLOGY INC.)

NOTES
TO FINANCIAL STATEMENTS (Continued)

16. RESEARCH AND DEVELOPMENT TAX CREDITS

The
Company qualifies as a small business under Internal Revenue Code Section 41(h) and has elected to apply a portion of its federal research